Navigation Links
Acute in Medical Technology

Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia

... extended-release injectable suspension for the acute and maintenance treatment of schizophrenia in ... The approval is based on four acute symptom control studies and a longer-term ... syndrome scale (PANSS) total scores in the acute treatment trials and significantly delayed time ...

Schering-Plough Announces U.S. Filing of Mometasone Furoate/Formoterol Fumarate Combination for the Maintenance Treatment of Asthma

... ASMANEX should not be used to treat acute asthma episodes (including status asthmaticus) ... inhalers. FORADIL AEROLIZER is also for the acute prevention of exercise-induced bronchospasm (EIB) ... FORADIL AEROLIZER should not be used to treat acute ....

Leading Experts Endorse Bioheart's Muscle Stem Cell MyoCell Therapy

... cell therapies for the treatment of chronic and acute heart damage. Its lead product candidate, ... the treatment of heart damage, including Bioheart acute Cell Therapy, an autologous, adipose tissue-derived stem cell treatment for acute heart damage, and MyoCell(R) SDF-1, a therapy ...

AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain

... Sufentanil NanoTabs(TM) for the management of acute post-operative pain in patients requiring opioid ... a major advance in the management of inpatient acute pain, liberating patients from the IV connection ... from placebo in both studies." About acute Post-Operative Pain Annually, approximately 8 ...

Glybera(TM) Shows Long-Term Health Benefits

... significant and clinically important reduction in acute pancreatitis in lipoprotein lipase deficient patients. Recurrent acute pancreatitis is the most debilitating ... significant, tenfold decrease in the incidence of acute pancreatitis. From the second trial in fourteen ...

FDA Advisory Committee Votes in Favor of Zyprexa for Two Adolescent Indications

... is effective and acceptably safe for the acute treatment of schizophrenia or manic or mixed ... in 107 adolescents (aged 13-17 years) with acute manic or mixed episodes associated with bipolar I ... measures. Symptoms of schizophrenia include acute episodes of delusions, hallucinations and ...

DOR BioPharma Receives EMEA Agreement on the Design of its Confirmatory Phase 3 Clinical Trial of orBec(R) in GI GVHD

... its lead product orBec(R) for the treatment of acute gastrointestinal Graft-versus-Host Disease (GI ... to address the significant unmet medical need of acute GI GVHD. We anticipate patient enrollment to ... market exclusivity, respectively. About acute GI GVHD ...

Micromet's Blinatumomab Achieves Primary Endpoint in Phase 2 Study with Acute Lymphoblastic Leukemia Patients

... Berlin, Germany, showing a high response rate in acute lymphoblastic leukemia (ALL) patients with ... (MRD) in patients with B precursor acute lymphoblastic leukemia (ALL): Update of an ... clinical trial for the treatment of patients with acute lymphoblastic leukemia (ALL), and in a phase 1 ...

Study Demonstrating Lurasidone Is Effective in Patients With Schizophrenia Published in The Journal of Clinical Psychiatry

... trial, involving 180 patients with acute schizophrenia, evaluated a single fixed dose of ... trial in the treatment of patients with acute schizophrenia," said Antony Loebel, M.D., senior ... over six weeks in patients hospitalized for an acute exacerbation of schizophrenia (diagnosed using ...

Neurobiological Technologies' Partner, Celtic Pharma, Announces Results of XERECEPT(R) Phase 3 Clinical Program

... usage and its associated side effects in both acute and long-term treatment of patients with edema ... XERECEPT(R) to dexamethasone for the control of acute symptoms associated with peritumoral edema, was ... in the treatment of patients presenting with an acute exacerbation of edema-associated symptoms. ...

Results and Additional Analyses From Study Show That Corthera's Relaxin for Acute Heart Failure is the Strongest Predictor of Improved Longer-Term Outcomes Following Hospital Discharge When Compared to Other Variables

... investigational drug for the treatment of acute heart failure (AHF), was the strongest ... therapy for patients admitted to hospital with acute heart failure," said Dr. Metra. Five ... need for improved therapies for patients with acute heart failure," said Piotr Ponikowski, M.D., ...

Results and Additional Analyses From Efficacy and Safety Study of Corthera's Relaxin in Acute Heart Failure to be Presented at Heart Failure Congress 2009

... investigational drug relaxin for the treatment of acute heart failure will be presented at the Heart ... commercializing therapies for illnesses in the acute care setting. Corthera's lead product candidate, ... currently being evaluated in clinical trials for acute heart failure. The company has worldwide rights ...

AMT Receives EMEA Orphan Drug Designation for Acute Intermittent Porphyria

... this Orphan Drug Designation for the treatment of acute intermittent porphyria," said Sander van ... and potentially lethal disease." About acute Intermittent Porphyria acute intermittent porphyria is a rare genetic disease ...

Scientific Data Relating to Cinryze(TM) Presented at 6th Annual C1 Inhibitor Deficiency Workshop

... Application for Cinryze for the treatment of acute attacks of HAE. If approved, Cinryze would be the first C1 esterase inhibitor available for the acute treatment for this condition. ViroPharma's PDUFA date for Cinryze in the acute setting is June 3, 2009. "With the C1 ...

New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal

... Confirm Tapentadol Efficacy and Tolerability for acute Pain Patients RARITAN, N.J., May 26 ... significant relief of moderate to severe acute pain after a bunionectomy, one of the most common ... effective analgesic relief of moderate to severe acute pain with fewer incidences of nausea and/or ...

Dainippon Sumitomo Pharma Announces Lurasidone Phase III Data in Patients With Schizophrenia

... more effective than placebo for the treatment of acute schizophrenia. In addition, lurasidone was ... to placebo, over six weeks in patients with acute schizophrenia. Patients were diagnosed with ... DSM-IV criteria) and were required to have an acute exacerbation of psychotic symptoms with a PANSS ...

Cadence Pharmaceuticals Submits Acetavance New Drug Application for the Treatment of Acute Pain and Fever

... (intravenous acetaminophen), for the treatment of acute pain and fever in adults and children. If ... one pivotal clinical trial for the treatment of acute pain in patients following orthopedic surgery and ... in the United States for the treatment of acute pain. Opioids may be associated with a variety of ...

CMC ICOS Biologics and Implicit Bioscience Ltd Announce IC14 Antibody Manufacturing Agreement and Patent License

... of IC14, a clinical-stage monoclonal antibody for acute lung injury (ALI). IC14 has a demonstrated ... forward on an accelerated basis." About acute Lung Injury acute lung injury (ALI) is a severe inflammatory ...

Alexza Reports 2009 First Quarter Financial Results and Updates Clinical Pipeline Status

... loxapine). Alexza is developing AZ-004 for the acute treatment of agitation in patients with ... AZ-104 to treat patients suffering from acute migraine headaches. AZ-104 is a lower dose ... of novel, proprietary products for the acute treatment of central nervous system conditions. ...

ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the Association for Research in Vision and Ophthalmology (ARVO) 2009 Annual Meeting

... Conjunctival Allergen Challenge (CAC) Model of acute Allergic Conjunctivitis", ISTA demonstrated ... Conjunctival Allergen Challenge (CAC) Model of acute Allergic Conjunctivitis", ISTA demonstrated ... Conjunctival Allergen Challenge (CAC) Model of acute Allergic Conjunctivitis Authors: J.A. Gow, ....

Anthera's Varespladib Meets Primary Endpoint in Phase 2 FRANCIS Trial for the Treatment of Acute Coronary Syndrome

... announced today that FRANCIS (Fewer Recurrent acute coronary events with Near-term Cardiovascular ... administered to patients within 96 hours of an acute Coronary Syndrome (ACS) event, met its primary ... a reduction in C-reactive protein. About acute Coronary Syndrome ...

New Analysis Evaluated Impact of Genetic Variation on Response to Prasugrel

... to prasugrel. In prasugrel-treated patients with acute coronary syndromes (ACS) who underwent an ... and fatal bleeding.(3) About acute Coronary Syndromes acute coronary syndromes, which is comprised of heart ...

Karmanos Cancer Institute Researchers Study New Drug Combinations to Treat Childhood Leukemia

... children who suffer from a more deadly form of acute leukemia. (Logo: ... drugs works synergistically to help children with acute myeloid leukemia (AML). Dr. Ge is an Assistant ... in bone marrow, accounts for one-fourth of acute leukemia in children and is responsible for more ...

Cephalon Announces Positive Results from a Phase Three Study of NUVIGIL in Jet Lag Disorder

... safety of NUVIGIL as a potential treatment for acute excessive sleepiness associated with jet lag ... study will allow us to file our first sNDA for an acute use of NUVIGIL." NUVIGIL was generally ... The adverse events reported in this study of acute use are consistent with chronic use in the ...

Schering-Plough Announces Results of the Early ACS Trial

... Provisional Use in Patients with High-Risk acute Coronary Syndrome, Study Finds KENILWORTH, ... (eptifibatide) routinely in patients with acute Coronary Syndrome (ACS), at least 12 hours prior ... IIb-IIIa Inhibition in Non-ST-Segment Elevation acute Coronary Syndrome (EARLY ACS) study, which was ...

Results From Study Show Promising Efficacy and Safety Results for Corthera's Relaxin in Acute Heart Failure

... company's investigational drug for treatment of acute heart failure (AHF). The report containing the ... administered with standard-of-care therapy for acute heart failure, relaxin caused rapid, substantial ... in hospitalization costs. The great majority of acute heart failure patients have fluid accumulation in ...

DOR BioPharma, Inc. Executes $400,000 Equity Investment Agreement With Numoda Corporation

... 3 clinical trial of orBec(R) for the treatment of acute gastrointestinal Graft-versus-Host disease (GI ... and excitement over the promise of orBec(R) in acute GI GVHD." Mary Schaheen, Numoda's Chief ... 3 clinical trial of orBec(R) for the treatment of acute GI GVHD and a Phase 1/2 clinical trial of DOR201 ...

Following Encouraging Results Anthera to Continue IMPACTS Trial for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease

... sodium) in preventing the development of acute chest syndrome in hospitalized sickle cell disease patients. Enrolled patients are at-risk for acute chest syndrome based on the combination of pain ... of the enzyme (secretory phospholipase or sPLA2). acute chest syndrome is a life-threatening complication ...

Results From Efficacy and Safety Study of Corthera's Relaxin in Acute Heart Failure to be Presented at Late-Breaking Clinical Trials Session at ACC 58th Annual Scientific Session

... investigational drug relaxin for the treatment of acute heart failure will be presented at 10:30 a.m. EDT ... commercializing therapies for illnesses in the acute care setting. Corthera's lead product candidate, ... currently being evaluated in clinical trials for acute heart failure. The company has worldwide rights ...

Schering-Plough's Investigational Oral Thrombin Receptor Antagonist Meets Primary Endpoint in a Newly Published Study

... data, along with subsequent data from Phase II acute coronary syndromes (ACS) and stroke studies ... Receptor Antagonist Clinical Event Reduction in acute coronary syndrome (TRA-CER) trial is a ... 10,000 patients with non-ST-segment elevation acute coronary syndrome. Patients will be randomized ...

CSL Behring Receives Orphan-Drug Exclusivity for RiaSTAP(TM), First and Only Approved Treatment of Acute Bleeding Episodes in Patients with Congenital Fibrinogen Deficiency

... is the first FDA-approved treatment of acute bleeding episodes in patients with congenital ... in January and is indicated for the treatment of acute bleeding episodes in patients with congenital ... concentrate indicated for the treatment of acute bleeding episodes in patients with congenital ...

Archimedes Pharma Announces Successful Proof-of-Concept Results on Two Intranasal Development Projects

... - Intranasal Diazepam for the Treatment of acute Repetitive Seizures in Epilepsy - Phase II ... drug approved specifically for the treatment of acute motor fluctuations/hypomobility (freezing or ... Parkinson's disease and intranasal Diazepam for acute repetitive seizures. Archimedes ...

Cordex Pharma Announces Strategic Master Services Equity Agreement With Cato BioVentures

... administered by intravenous injection for the acute termination of PSVT. The bradycardic effect of ... adenosine is the only approved drug for the acute treatment of PSVT in the United States. Cordex ... 505(b)(2). In addition to its use as an acute therapeutic, ATPace is expected to become the ...

Results of NeuroThera Effectiveness and Safety Trial - 2 (NEST-2) Presented at International Stroke Conference 2009

... Inc., transcranial laser therapy (TLT) for acute ischemic stroke within 24 hours of stroke onset ... of the NEST-3 Steering Committee. About acute Ischemic Stroke According to the American ... laser therapy (TLT) for the treatment of acute ischemic stroke and other neurological diseases ...

Early Switch from IV to Oral Meds Is Effective for Children with Acute Bone Infection

... -- When treating children for acute osteomyelitis--a bacterial bone infection--an ... to directly compare the two practices." acute osteomyelitis annually affects at least one in ... toward early transition to oral medication for acute osteomyelitis in children," added Zaoutis. He ...

Data Suggests New Antigen-Antibody Combo Test Useful for High Volume Public Health Screening

... screening to identify individuals with acute HIV infection, who would be missed by traditional ... at Abbott. "The current method for detection of acute infections is expensive and labor- intensive ... benefits for HIV prevention strategies." acute HIV infection, the early phase of infection when ...

FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE)

... - PDUFA Date for Cinryze for acute HAE Indication is June 3, 2009 - EXTON, ... Cinryze C1 Inhibitor (human) as a treatment for acute attacks of Hereditary Angioedema (HAE). The ... and resubmission of data from a pivotal Phase 3 acute treatment study of Cinryze and interim data from ...

The Leukemia & Lymphoma Society and Celator Pharmaceuticals Announce Partnership to Accelerate Development of CPX-351 for AML

... Liposome Injection for treatment of adults with acute myeloid leukemia (AML). Through the ... years of age with untreated AML. About acute Myeloid Leukemia (AML) The National Cancer ... currently in Phase 2 in patients with acute myeloid leukemia; CPX-1 (a liposomal formulation ...

Alexza Initiates AZ-104 (Staccato(R) Loxapine) Phase 2b Clinical Trial in Patients With Migraine Headaches

... is in late Phase 3 clinical development for the acute treatment of agitation in patients ... of migraine headaches." About acute Migraine Headaches According to the ... novel, proprietary products for the treatment of acute and intermittent conditions. The Company's ...

Anesiva Announces FDA Approval of Supplemental New Drug Application to Expand Zingo(TM) Indication

... drug candidate for the management of acute pain following orthopedic surgeries. Anesiva is ... is currently in development for the management of acute pain following orthopedic surgeries. Adlea has ... in multiple indications for site-specific, acute and chronic, moderate-to-severe pain. In ...
Other Contents
(Date:10/14/2014)... – Scientists have sequenced the house fly genome for ... might expect from an insect that thrives in pathogen-rich ... Oct. 14 in the journal Genome Biology , ... and of how flies quickly adapt to resist insecticides, ... house flies (Musca domestica) carry and transmit more than ...
(Date:10/14/2014)... – October 14, 2014 – Scientists from The Scripps ... the National Institutes of Health (NIH) to lead an ... hemorrhagic fever disease in Africa. The study aims to ... some patients die, while others survive the inflection. ... the basic mechanism of how Lassa fever virus causes ...
(Date:10/14/2014)... October 14, 2014 – Over the past decades, we ... institutions to meet the needs of infants for social ... these infants to thrive. , Infancy and ... of the cortex. A generation of research suggests that ... cortical development and cognitive function. In contrast, deprivation and ...
Breaking Biology News(10 mins):House fly genome reveals expanded immune system 2Scripps Research Institute team receives $6.6 million to investigate deadly Lassa virus 2Institutional rearing may increase risk attention-deficit disorder 2
(Date:10/19/2014)... 20, 2014 The leading review ... http://www.top10bestseohosting.com/go/iPage/ ) and GreenGeeks are the best Dedicated ... for those who want to buy high quality ... , The IT manager of Top10BestSEOHosting.com says, “We ... recommended suppliers for everyone. A lot of the ...
(Date:10/19/2014)... UNITED NATIONS, New York (PRWEB) October 19, 2014 ... the United Nations Population Fund, welcomes news of a ... release of the more than 200 girls who were ... Girls. "These girls have languished in captivity long enough, ... their families, schools and communities," stated Dr. Osotimehin. , ...
(Date:10/19/2014)... October 20, 2014 Having been working in ... good knowledge of customer needs. According to James, one of ... with dazzling sequins, or with high-low skirts that add beauty ... huge demand. Recently, LunaDress has unveiled its new selection of ... fact, the company’s brand new items are available in over ...
(Date:10/19/2014)... Recently, Fancyflyingfox.com, an innovative company that provides many ... latest designs of 2014 mother of the bride ... are offered with big discounts, up to 70% off. ... can enjoy this special offer. , Owing to ... become one of the leading brands in the global ...
(Date:10/19/2014)... NC (PRWEB) October 19, 2014 ... building program has just been released to the ... the online body building and fitness community. The ... attention of DietsAndFitnessGuides.com's Vin Delmonico prompting an investigative ... experience of hitting what is commonly known as ...
Breaking Medicine News(10 mins):Health News:Top10BestSEOHosting.com Considers iPage And GreenGeeks As The Best Dedicated Server Hosting Suppliers 2Health News:2014 Long Prom Dresses From LunaDress Now Available In Over 20 Popular Designs 2Health News:Fancyflyingfox.com Updates Its Website With New Mother Of The Bride Dresses For 2014 2Health News:Visual Impact Frequency Training Review: Rusty Moore's Latest Fitness Guide Released 2
Other TagsOther Tags